Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 CAD | +3.23% | 0.00% | +60.00% |
04-18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
04-11 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
Sales 2022 | 0.19 0.26 15.18 | Sales 2023 | 0.25 0.34 20.04 | Capitalization | 591K 808K 47.3M |
---|---|---|---|---|---|
Net income 2022 | -8M -10.94M -640M | Net income 2023 | - 0 0 | EV / Sales 2022 | 5,759,850 x |
Net cash position 2022 | 680K 930K 54.45M | Net cash position 2023 | 345K 471K 27.59M | EV / Sales 2023 | 983,765 x |
P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-1.97
x | Employees | 2 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.86% |
1 day | +3.23% | ||
Current month | -20.00% | ||
1 month | +28.00% | ||
3 months | +60.00% | ||
6 months | +60.00% | ||
Current year | +60.00% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 30/06/19 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 06/01/23 |
Andrew Hegle
BRD | Director/Board Member | 46 | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 30/06/19 |
Andrew Hegle
BRD | Director/Board Member | 46 | 31/12/19 |
Director/Board Member | 53 | 04/11/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.16 | +3.23% | 525 |
25/04/24 | 0.155 | -22.50% | 500 |
24/04/24 | 0.2 | -13.04% | 53,817 |
22/04/24 | 0.23 | +43.75% | 1,600 |
19/04/24 | 0.16 | +3.23% | 29,200 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 04:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+60.00% | 1.04M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ENBI Stock